Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

New England Journal of Medicine
December 16, 2021 Vol. 385 No. 25
http://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine A.R. Falsey and Others